跳至主要内容
临床试验/NCT03136081
NCT03136081已完成不适用

IMMUNOCANDIDA Candida Host Defense Response After Septic Shock in the Critically Ill

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Candidiasis infection occurence

研究概览

简要总结

Septic shock is associated with acquired immunoparalysis which is associated with a high risk of nosocomial acquired infection. Nosocomial candidiasis is associated with a 50% rate of mortality but is difficult to diagnose. The use of colonization indexes and risk factors on the other hand expose to unnecessary use of antifungals. The aim of the present study is to evaluate whether the host response to infection associated with candida biomarkers would help to anticipate the candidiasis onset.

详细描述

Single center prospective observationnal study. Inclusion: all consecutive patients subsequently to a septic shock with no Candida infection.

Measured parameters: host response (HLADR, CD64, inflammatory cytokines consecutive to LPS exposition) and Candida biomarkers (beta D Glucan, Mannan Ag and Ig), demographics, outcome (occurence of Candida nosocomial infection, morbidity and survival)

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > = 18 years
  • The patients in toxic shock defined according to the Bone criteria
  • Informed consent of the patient or his reliable person (poursuit consent in this case). Possibility of inclusion according to the emergency procedure with the obligation of research for the consent with the reliable person and with the patient.
  • Obligation of membership or beneficiary to have a national insurance

排除标准

  • Pregnant or breast-feeding women according to the article L1121-5 of the CSP
  • Vulnerable people according to the article L1121-6 of the CSP 9358 _ "
  • Neutropénie 500 / mm3
  • Infection by the HIV, the hepatitis C or B active column
  • Biotherapics (anti-CD20, anti-TNFa, anti-IL-6)
  • Treatments immunosuppresseurs (methotrexate, azathioprine, cyclophosphamide, mycophenolate mofétil, cyclosporine, tacrolimus)
  • Corticosteroid therapy = 1mg / kg of equivalent prednisone for more than a month
  • Toxic shock due to a deep candidiasis in the admission in resuscitation
  • Congenital deficits of Th17 (cutanéo-mucous candidiasis chronicles, syndrome of hyper IgE)

结局指标

主要结局

Candidiasis infection occurence

时间窗: Day 28 survival

Outcome

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验